Cardiovascular and Renal Drugs Advisory Committee


Open Public Hearing Printed Statements

June 15, 2005


Charles L. Pamplin, III, M.D.

Vice President, Medical Affairs

King Pharmaceuticals, Inc



Open Public Hearing Printed Statements

June 16, 2005


Shomarka Omar Y. Keita, M.D., D.Phil.

Medical Officer, Department of Human Services, District of Columbia Government

Senior Research Associate, National Human Genome Center, Howard University

Research Associate, Anthropology Department, Smithsonian Institution


The Honorable Donna M. Christensen

Member of Congress

Chair of the Congressional Black Caucus Health Braintrust


Gary A. Puckrein, Ph.D.

Executive Director, National Minority health Month Foundation


Jonathan Kahn, J.D., Ph.D.

Assistant Professor, Hamline University School of Law


Charles L. Curry, M.D., FACC, FACP

President, International Society on Hypertension in Blacks

Profess of Medicine Emeritus, Howard University


Olivia Carter-Pokras, Ph.D.

Associate Professor, University of Maryland, School of Medicine


Lucille C. Norville Perez, M.D.

National Health Director, National Association for the Advancement of Colored People


Perry W. Payne, Jr., M.D., J.D., MPP

Project Manager/Co-Investigator

CEER Planning Grant for Center on Genomics and Social Identity in the African Diaspora

National Human Genome Center, Howard University